Answers are grounded in this paper and cite their sources.
Background: Tuberculosis (TB) is a significant public health challenge in India, exacerbated by inadequate treatment adherence and stigma. Methods: A cross-sectional study at directly observed treatment short-course centers in Gangtok evaluated treatment adherence and stigma among 261 TB patients using validated tools and SPSS version 27.0 for data analysis. Results: Among 261 participants, 56.3% were aged 18–33 years, 50.2% were male, 60.9% were Hindu, and 52.1% were married. About 45.3% belonged to the high-income group, 26.1% were graduates, and 28.4% were students, businesspersons, or retirees. Most lived in urban areas (71.6%) and pucca houses (93.9%), with 52.2% from nuclear families and 50.6% having 1–3 members. Clinically, 89.7% had no comorbidities, 70.1% were on a 6-month regimen, 65.9% were in the continuation phase, and 41% were newly diagnosed with drug-sensitive TB. Regarding outcomes, 62.8% were non-stigmatized (95% CI: 56.8–68.5; mean 37.48 ± 12.48) and 82.8% showed good adherence (95% CI: 77.7–86.9; mean 22.13 ± 5.08). A significant moderate positive correlation was found between stigma and adherence (r = 0.390, P < 0.001). No association was observed between adherence and demographic or clinical variables, whereas stigma showed significant associations with age, education, income, drug category, and treatment phase. Conclusion: Participants generally exhibited good adherence and low stigma, with a significant correlation between stigma and adherence, while demographic and clinical variables did not significantly relate to adherence.
No takes yet. Share an insight, caveat, or question.
Devi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: